A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response is a research paper published in UNC Libraries (2021). On theSindex it has a DataRank of 0.881. It has been cited 26 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0.387
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
National Institutes of Health
Grant: 5P50CA090578-07
Foxa2 and C/EBP transcription factors in the pathogenesis and treatment of lung c
National Institutes of Health
Grant: 5RC2CA147940-02
The Co-Clinical Project: Informing clinical trials using preclinical mouse models
National Institutes of Health
Grant: 5U01CA141576-03
LKB1 tumor suppressor and human cancer
National Institutes of Health
Grant: 5R01CA140594-02
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
National Institutes of Health
Grant: 5R01CA122794-09
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
National Institutes of Health
Grant: 3R01CA137181-01A2S1
Mouse Models and Translational Studies of Endometrial Cancer
National Institutes of Health
Grant: 2R01CA137008-06
Impact of heterogeneity on response to EGFR T790M inhibitors
Fields of Study
Keywords
Sustainable Development Goals